ProfileGDS5678 / 1418430_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 98% 98% 98% 98% 98% 98% 97% 98% 98% 98% 99% 98% 98% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 19.9306998
GSM967853U87-EV human glioblastoma xenograft - Control 29.9037898
GSM967854U87-EV human glioblastoma xenograft - Control 310.045598
GSM967855U87-EV human glioblastoma xenograft - Control 410.00798
GSM967856U87-EV human glioblastoma xenograft - Control 59.9224498
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 19.7389898
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 29.1759797
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 39.5907898
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 49.7762498
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.395898
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 210.681999
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.151298
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.270198
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.403698